Enhancement of UDP-Arabinose Supply and Engineering of Glycosyltransferase DaUGT121 from Dipsacus asperoides for Cauloside A Biosynthesis in Escherichia coli
Tengfei Niu , Weilin Yao , Xuxuan Zhang , Yuan Ji , Li Yang , Zhengtao Wang , Mattheos A.G. Koffas , Rufeng Wang
Engineering ››
Cauloside A (hederagenin 3-O-α-L-arabinopyranoside) is a bioactive triterpenoid saponin with demonstrated anti-inflammatory, antimicrobial, cytotoxic, hemolytic, and molluscicidal properties. However, its structurally complex nature and limited natural availability make both large-scale chemical synthesis and extraction from medicinal plants particularly challenging. Microbial conversion via heterologous expression of glycosyltransferases provides a convenient and sustainable approach to produce cauloside A. Consequently, the efficient supply of uridine diphosphate-arabinose (UDP-Ara) is a critical determinant of the microbial synthesis of glycosides. In this study, we first engineered Escherichia coli (E. coli) to express pathway enzymes, enabling the accumulation of UDP-glucose, UDP-glucuronic acid, UDP-xylose, and UDP-Ara. The biosynthesis of UDP-Ara was subsequently enhanced through pathway optimization and the implementation of a uridine triphosphate regeneration system. Additionally, a salvage pathway comprising arabinose kinase and UDP-sugar pyrophosphorylase was engineered to increase the supply of UDP-Ara in E. coli. Finally, the production of cauloside A was achieved for the first time by introducing the engineered glycosyltransferase DaUGT121 from Dipsacus asperoides into UDP-Ara-producing strains. Through fed-batch fermentation in a 5 L bioreactor, the concentration of cauloside A reached 435.6 mg∙L–1. This study presents an efficient and scalable strategy for the biosynthesis of other high-value arabinose-derived natural products.
Uridine diphosphate-arabinose / Salvage pathway / Cauloside A / Glycosyltransferase / DaUGT121
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
/
| 〈 |
|
〉 |